CN Patent

CN102985557A — 用于细胞增殖相关病症的方法和组合物

Assigned to Les Laboratoires Servier SAS · Expires 2013-03-20 · 13y expired

What this patent protects

本文描述了治疗和评估具有新活性突变体的受试者的方法。

USPTO Abstract

本文描述了治疗和评估具有新活性突变体的受试者的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN102985557A
Jurisdiction
CN
Classification
—
Expires
2013-03-20
Drug substance claim
No
Drug product claim
No
Assignee
Les Laboratoires Servier SAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.